Skip to Main Content

National Coverage Analysis (NCA) for Autologous Blood-Derived Products for Chronic Non-Healing Wounds (CAG-00190R3)

Expand/collapse the Contacts section

Contact(s)

James Rollins, MD, PhD

Lisa Eggleston, RN, MS

Lisa.eggleston@cms.hhs.gov

410-786-6130

Back to Top

Expand/collapse the Documents section

Documents

Tracking Sheet

Proposed Decision Memo

Decision Memo

View Public Comments

NCD for Blood-Derived Products for Chronic Non-Healing Wounds (270.3)

Back to Top

Expand/collapse the History of Considerations section

History of Considerations

Original Consideration for Autologous Blood-Derived Products for Chronic Non-Healing Wounds (CAG-00190N)

First reconsideration for Non-Autologous Blood Derived Products for Chronic Non-Healing Wounds (CAG-00190R)

Second reconsideration for Autologous Blood Derived Products for Chronic Non-Healing Wounds (CAG-00190R2)

Third reconsideration for Autologous Blood-Derived Products for Chronic Non-Healing Wounds (this document)

Back to Top

Footer Links

www